S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TSBX Turnstone Biologics Corporation

0.4458

-0.0324 (-6.78%)

08 Feb 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Turnstone Biologics Charts.

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Turnstone Biologics Charts.

Turnstone Biologics Corporation News

Form 8-K - Current report
Wednesday 5 February 2025 (4 days ago) • Edgar (US Regulatory)

Turnstone Biologics Announces Plans to Explore Strategic Alternatives
Wednesday 5 February 2025 (4 days ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Wednesday 6 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 11 October 2024 (4 months ago) • Edgar (US Regulatory)

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Friday 11 October 2024 (4 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 2 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 15 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 August 2024 (6 months ago) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Thursday 15 August 2024 (6 months ago) • GlobeNewswire Inc.

More Turnstone Biologics Corporation News Articles

Societe Generale Effekten

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions